- Neocate is a hypoallergenic, amino acid-based formulae (AAF) intended for use in dietary management of Cow’s Milk Allergy.
- Neocate is a Food for Special Medical Purposes (FSMP) backed by 40 years of innovation in allergy at Danone Nutricia.
New Delhi, August 25, 2017: Danone India today announced the launch of its global brand Neocate in India which is a hypoallergenic, amino acid-based formula (AAF) intended for use in dietary management of Cow’s Milk Allergy, the most common food allergy in infants and young children globally.
Commenting on the launch of Neocate in India, Pierre Andre Terisse, Executive Vice President, Africa and India said, “At Danone, we are committed to encourage healthy, balanced nutrition for mothers, babies and toddlers. Danone has an extensive range of tailored nutrition products that guarantee nutrition combining quality, diversity and taste. With Neocate, we are able to cater to the special needs of infants with Cow’s Milk Allergy to help them in leading a normal healthy life.”
Commenting on the launch, Rodrigo Lima, Managing Director, Danone India said, “The launch of Neocate is a step towards realising our ambition for India, by bringing global solutions for the management of CMA. Neocate will help to address the growing challenges of healthcare professionals and parents in the dietary management of Cow’s Milk Allergy, making everyday life little easier for families.”
Cow’s milk allergy is a result of one or more cow’s milk proteins triggering an adverse reaction by our body’s immune system. . Managing cow’s milk allergy involves removal of cow’s milk and dairy products from the diet. World over, the recommended management of infants with cow’s milk allergy is extensively hydrolyzed protein or amino acid-based formulae such as Neocate.
Neocate will be retailed on Amazon.in and will also be available at pharmacies in select Indian cities that include Lucknow, Varanasi, Delhi NCR, Jalandhar, Amritsar, Ludhiana, Jaipur, Mumbai, Pune, Nagpur, Ahmedabad, Kolkata, Hyderabad, Vijayawada, Vizag, Bangalore, Chennai, Coimbatore, Cochin, Madurai.
1 In a study conducted in a tertiary care hospital in India, 3 out of 10 children with chronic diarrhea were estimated to be suffering from Cow’s Milk Allergy. Globally the prevalence rate of CMA is approx. 3 -5%.
Neocate is a hypoallergenic amino acid-based formula (AAF) meant for infants with Cow’s Milk Allergy, multiple food protein allergies and a range of other food allergy induced disorders. It is based on 100% free amino acids and does not contain any Cow’s Milk protein. Neocate should always be used under medical supervision.
Neocate is part of Danone’s pioneering solutions in allergy and reflects our culture of innovation in delivering the best in allergy care. Neocate is manufactured under stringent conditions at a dedicated factory in Liverpool in a Cow’s Milk-free environment and packaged in a protective atmosphere to ensure hypo allergenicity and top quality. Neocate is supported by over 25 years of clinical evidence to support its safety and efficacy in the dietary management of CMA and related conditions.
About Danone India
Dedicated to bringing health through food to as many people as possible, Danone is a leading global food company built on four business lines: Essential Dairy and Plant-Based Products, Early Life Nutrition, Waters and Medical Nutrition. With products being present in over 130 markets, Danone generated sales of approximately €22 billion in 2016. In India, Danone started its dairy business in 2010, while the nutrition business was started in 2012 through the acquisition of the nutrition portfolio from Wockhardt Group. Danone Dairy has wooed the Indian consumer with its UHT and fresh dairy innovations that are tailored for Indian market such as mishti doi, chaas, lassi, dahi, flavoured yoghurts and smoothies. Danone’s life nutrition business (Nutricia) embodies a holistic nutrition approach offering a full range of products for pregnant mothers, infants, young children as well as adults, under recognized brands like Aptamil Farex, Protinex, Dexolac and Nusobee.